Sign in or Register   Sign in or Register
  |  

Mouse Anti-ITGB3 Recombinant Antibody (RUU-PL7F12) (CBMAB-C11887-LY)

The product is antibody recognizes ITGB3. The antibody RUU-PL7F12 immunoassay techniques such as: FC.
See all ITGB3 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
RUU-PL7F12
Antibody Isotype
IgG1, κ
Application
FC

Basic Information

Specificity
Human
Antibody Isotype
IgG1, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Integrin Subunit Beta 3
Introduction
The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008]
Entrez Gene ID
UniProt ID
Alternative Names
Integrin Subunit Beta 3
Function
Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. Fibrinogen binding enhances SELP expression in activated platelets (By similarity).
ITGAV:ITGB3 binds to fractalkine (CX3CL1) and acts as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415, PubMed:24789099).
ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778).
ITGAV:ITGB3 binds to FGF1 and this binding is essential for FGF1 signaling (PubMed:18441324).
ITGAV:ITGB3 binds to FGF2 and this binding is essential for FGF2 signaling (PubMed:28302677).
ITGAV:ITGB3 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:19578119).
ITGAV:ITGB3 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464).
ITGAV:ITGB3 binds to IL1B and this binding is essential for IL1B signaling (PubMed:29030430).
ITGAV:ITGB3 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877).
ITGAV:ITGB3 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887).
In brain, plays a role in synaptic transmission and plasticity. Involved in the regulation of the serotonin neurotransmission, is required to localize to specific compartments within the synapse the serotonin receptor SLC6A4 and for an appropriate reuptake of serotonin. Controls excitatory synaptic strength by regulating GRIA2-containing AMPAR endocytosis, which affects AMPAR abundance and composition (By similarity).
ITGAV:ITGB3 act as a receptor for CD40LG (PubMed:31331973).
(Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Herpes virus 8/HHV-8.
(Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Coxsackievirus A9.
(Microbial infection) Acts as a receptor for Hantaan virus.
(Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Cytomegalovirus/HHV-5.
(Microbial infection) Integrin ITGA5:ITGB3 acts as a receptor for Human metapneumovirus.
(Microbial infection) Integrin ITGAV:ITGB3 acts aP05556s a receptor for Human parechovirus 1.
(Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for West nile virus.
(Microbial infection) In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
Biological Process
Activation of protein kinase activityManual Assertion Based On ExperimentIMP:BHF-UCL
Angiogenesis involved in wound healingManual Assertion Based On ExperimentTAS:BHF-UCL
Apolipoprotein A-I-mediated signaling pathwayManual Assertion Based On ExperimentIMP:UniProtKB
Apoptotic cell clearanceManual Assertion Based On ExperimentIGI:BHF-UCL
Blood coagulationManual Assertion Based On ExperimentTAS:ProtInc
Cell adhesionManual Assertion Based On ExperimentTAS:ProtInc
Cell adhesion mediated by integrinManual Assertion Based On ExperimentIDA:UniProtKB
Cell migrationManual Assertion Based On ExperimentIBA:GO_Central
Cell-matrix adhesionManual Assertion Based On ExperimentIMP:UniProtKB
Cell-substrate adhesionManual Assertion Based On ExperimentIMP:UniProtKB
Heterotypic cell-cell adhesionManual Assertion Based On ExperimentIMP:UniProtKB
Integrin-mediated signaling pathwayManual Assertion Based On ExperimentHDA:UniProtKB
Mesodermal cell differentiationManual Assertion Based On ExperimentIEP:UniProtKB
Negative chemotaxisManual Assertion Based On ExperimentIMP:UniProtKB
Negative regulation of lipid storageManual Assertion Based On ExperimentIMP:BHF-UCL
Negative regulation of lipid transportManual Assertion Based On ExperimentIMP:BHF-UCL
Negative regulation of lipoprotein metabolic processManual Assertion Based On ExperimentIMP:BHF-UCL
Negative regulation of low-density lipoprotein receptor activityManual Assertion Based On ExperimentIMP:BHF-UCL
Negative regulation of macrophage derived foam cell differentiationManual Assertion Based On ExperimentIMP:BHF-UCL
Platelet activationManual Assertion Based On ExperimentIMP:UniProtKB
Platelet aggregationManual Assertion Based On ExperimentIMP:UniProtKB
Positive regulation of endothelial cell migrationManual Assertion Based On ExperimentIMP:BHF-UCL
Positive regulation of endothelial cell proliferationManual Assertion Based On ExperimentIMP:BHF-UCL
Positive regulation of peptidyl-tyrosine phosphorylationManual Assertion Based On ExperimentIMP:BHF-UCL
Positive regulation of protein phosphorylationManual Assertion Based On ExperimentTAS:BHF-UCL
Positive regulation of vascular endothelial growth factor receptor signaling pathwayManual Assertion Based On ExperimentTAS:BHF-UCL
Regulation of bone resorptionManual Assertion Based On ExperimentTAS:BHF-UCL
Regulation of postsynaptic neurotransmitter receptor internalizationManual Assertion Based On ExperimentIDA:SynGO
Regulation of protein localizationISS:UniProtKB
Regulation of serotonin uptakeISS:UniProtKB
Smooth muscle cell migrationManual Assertion Based On ExperimentIMP:BHF-UCL
Substrate adhesion-dependent cell spreadingManual Assertion Based On ExperimentIDA:UniProtKB
Tube developmentManual Assertion Based On ExperimentTAS:BHF-UCL
Viral entry into host cellManual Assertion Based On ExperimentIMP:UniProtKB
Wound healing1 PublicationIC:BHF-UCL
Cellular Location
Cell membrane; Cell projection, lamellipodium membrane; Cell junction, focal adhesion; Cell junction, synapse, postsynaptic cell membrane; Cell junction, synapse
Involvement in disease
Glanzmann thrombasthenia 2 (GT2):
A form of Glanzmann thrombasthenia, a disorder characterized by failure of platelet aggregation, absent or diminished clot retraction, and mucocutaneous bleeding of mild-to-moderate severity. Glanzmann thrombasthenia has been classified into clinical types I and II. In type I, platelets show absence of glycoprotein IIb-IIIa complexes at their surface and lack fibrinogen and clot retraction capability. In type II, the platelets express glycoprotein IIb-IIIa complexes at reduced levels, have detectable amounts of fibrinogen, and have low or moderate clot retraction capability.
Bleeding disorder, platelet-type, 24 (BDPLT24):
An autosomal dominant disorder of platelet production characterized by congenital macrothrombocytopenia and platelet anisocytosis. Affected individuals may have no or only mildly increased bleeding tendency.
Topology
Extracellular: 27-718
Helical: 719-741
Cytoplasmic: 742-788
PTM
Phosphorylated on tyrosine residues in response to thrombin-induced platelet aggregation. Probably involved in outside-in signaling. A peptide (AA 740-762) is capable of binding GRB2 only when both Tyr-773 and Tyr-785 are phosphorylated. Phosphorylation of Thr-779 inhibits SHC binding.

Gao, Y., Fang, Y., Huang, Y., Ma, R., Chen, X., Wang, F., ... & Li, P. (2022). MIIP functions as a novel ligand for ITGB3 to inhibit angiogenesis and tumorigenesis of triple-negative breast cancer. Cell Death & Disease, 13(9), 810.

Cheng, C., Liu, D., Liu, Z., Li, M., Wang, Y., Sun, B., ... & Pan, S. (2022). Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. Cancer Science, 113(9), 2986-3001.

Ross, J. E., Zhang, B. M., Lee, K., Mohan, S., Branchford, B. R., Bray, P., ... & Di Paola, J. (2021). Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen platelet disorder variant curation panel. Blood Advances, 5(2), 414-431.

Feng, W., Huang, W., Chen, J., Qiao, C., Liu, D., Ji, X., ... & Xia, L. (2021). CXCL12-mediated HOXB5 overexpression facilitates colorectal cancer metastasis through transactivating CXCR4 and ITGB3. Theranostics, 11(6), 2612.

Li, D., Peng, J., Li, T., Liu, Y., Chen, M., & Shi, X. (2021). Itgb3-integrin-deficient mice may not be a sufficient model for patients with Glanzmann thrombasthenia. Molecular Medicine Reports, 23(6), 1-10.

Fuentes, P., Sesé, M., Guijarro, P. J., Emperador, M., Sánchez-Redondo, S., Peinado, H., ... & Ramón y Cajal, S. (2020). ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells. Nature communications, 11(1), 4261.

Zhu, C., Kong, Z., Wang, B., Cheng, W., Wu, A., & Meng, X. (2019). ITGB3/CD61: a hub modulator and target in the tumor microenvironment. American journal of translational research, 11(12), 7195.

Hu, L., Zang, M. D., Wang, H. X., Zhang, B. G., Wang, Z. Q., Fan, Z. Y., ... & Zhu, Z. G. (2018). G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner. Cell death & disease, 9(3), 278.

Nurden, A. T., & Pillois, X. (2018). ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia. Platelets, 29(1), 98-101.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-ITGB3 Recombinant Antibody (RUU-PL7F12)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare